Insider Transactions in Q2 2022 at Phase Bio Pharmaceuticals Inc (PHAS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
11,248
-100.0%
|
$0
$0.79 P/Share
|
|
May 20
2022
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,026
+8.39%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Jonathan Birchall Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,831
+36.34%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
11,248
+50.0%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+7.61%
|
$0
$0.68 P/Share
|
|
May 20
2022
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,917
+20.93%
|
$0
$0.68 P/Share
|